SEMA6D Expression and Patient Survival in Breast Invasive Carcinoma

Tantravahi, S. K., Albertson, D., Agarwal, A. M., Ravulapati, S., Poole, A., Patel, S. B., Hawatmeh, J. S., Straubhar, A. M., Liu, T., Stenehjem, D. D., & Agarwal, N. (2015). Survival Outcomes and Tumor IMP3 Expression in Patients with Sarcomatoid Metastatic Renal Cell Carcinoma. Journal of Oncology, 2015(), 370-375. https://doi.org/10.1155/2015/181926
Consul, N., Guo, X., Coker, C., Pintado, S. L., Hibshoosh, H., Zhao, B., Kalinsky, K., & Acharyya, S. (2016). Monitoring Metastasis and Cachexia in a Patient with Breast Cancer: A Case Study. Clinical Medicine Insights: Oncology, (), 83-94. https://doi.org/10.4137/CMO.S40479
Makki, J. (2015). Diversity of Breast Carcinoma: Histological Subtypes and Clinical Relevance. Clinical Medicine Insights：Pathology, (), 23-31. https://doi.org/10.4137/CPath.S31563
Badruddoja, M. (2012). Ductal Carcinoma In Situ of the Breast: A Surgical Perspective. International Journal of Surgical Oncology, 2012(), 408-419. https://doi.org/10.1155/2012/761364
Guiu, S., Reynier, M. A. M., Toure, M., & Coudert, B. (2013). Predictive Factors of Response in HER2-Positive Breast Cancer Treated by Neoadjuvant Therapy. Journal of Oncology, 2013(), 155-163. https://doi.org/10.1155/2013/854121